TG Therapeutics Inc. Stock
Price
Target price
€35.00
€35.00
0.580%
0.2
0.580%
€46.39
04.06.26 / Tradegate
WKN: A1JXW7 / Symbol: TGTX / Name: TG Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
TG Therapeutics Inc. Stock
The TG Therapeutics Inc. stock is trending slightly upwards today, with an increase of €0.20 (0.580%) compared to yesterday's price.
With 8 Buy predictions and not the single Sell prediction the community is currently very high on TG Therapeutics Inc..
As a result the target price of 46 € shows a positive potential of 31.43% compared to the current price of 35.0 € for TG Therapeutics Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for TG Therapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of TG Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of TG Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| TG Therapeutics Inc. | 0.580% | 3.858% | 14.754% | 7.842% | 34.641% | 41.129% | 21.107% |
| Heron Therapeutics Inc. | -6.370% | -50.806% | -65.076% | -79.122% | -67.145% | -65.143% | -96.715% |
| Evolus Inc | -3.070% | -0.937% | 1.439% | -33.759% | 0.881% | -32.540% | -38.570% |
| Rhythm Pharmaceuticals | -1.320% | -1.974% | -4.487% | 31.858% | -20.321% | 362.733% | 390.132% |
Comments
TG Therapeutics (TGTX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $70.00 price target on the stock.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (TGTX) had its "buy" rating reaffirmed by HC Wainwright.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (NASDAQ:TGTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $49.00 to $46.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TGTX provided by MarketBeat